DEPAKOTE

LOE Approaching

divalproex sodium

NDAORALTABLET, DELAYED RELEASE
Approved
Mar 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

tract. The mechanisms by which valproate exerts its therapeutic effects have not been established. It has been suggested that its activity in epilepsy is related to increased brain concentrations of gamma-aminobutyric acid (GABA).

Clinical Trials (5)

NCT00579280Phase 4Completed

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD

Started Jul 2007
224 enrolled
Bipolar DisorderPanic DisorderGeneralized Anxiety Disorder
NCT01075126Phase 4Withdrawn

Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder

Started Dec 2006
50 enrolled
Bipolar Disorder
NCT00974012Phase 1Completed

Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions

Started Oct 2006
24 enrolled
Healthy
NCT00864006Phase 1Completed

Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions

Started Oct 2006
28 enrolled
Seizures
NCT00974441Phase 1Completed

Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions

Started Aug 2006
48 enrolled
Healthy